Abrar Choudhury, M.D.,Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Meningeal Neoplasms | 19 | 2025 | 1251 | 3.380 |
Why?
|
Meningioma | 18 | 2025 | 1222 | 3.270 |
Why?
|
Neurofibromin 2 | 3 | 2024 | 272 | 0.590 |
Why?
|
Genetic Heterogeneity | 4 | 2024 | 738 | 0.490 |
Why?
|
Hedgehog Proteins | 3 | 2021 | 770 | 0.390 |
Why?
|
Tumor Microenvironment | 4 | 2025 | 3939 | 0.330 |
Why?
|
DNA Methylation | 4 | 2024 | 4421 | 0.320 |
Why?
|
Mammary Glands, Animal | 3 | 2018 | 273 | 0.290 |
Why?
|
Cilia | 2 | 2021 | 499 | 0.270 |
Why?
|
Mammary Glands, Human | 2 | 2017 | 202 | 0.230 |
Why?
|
Neoplastic Stem Cells | 3 | 2024 | 1357 | 0.230 |
Why?
|
Solitary Fibrous Tumors | 1 | 2025 | 70 | 0.230 |
Why?
|
Radiation Tolerance | 1 | 2024 | 478 | 0.200 |
Why?
|
Intramolecular Transferases | 1 | 2021 | 14 | 0.190 |
Why?
|
Sterols | 1 | 2021 | 64 | 0.180 |
Why?
|
RNA Splicing | 1 | 2024 | 906 | 0.170 |
Why?
|
Dogs | 1 | 2024 | 3847 | 0.170 |
Why?
|
Oxidoreductases Acting on CH-CH Group Donors | 1 | 2021 | 173 | 0.170 |
Why?
|
Neurilemmoma | 1 | 2024 | 524 | 0.150 |
Why?
|
Cyclin-Dependent Kinase 6 | 1 | 2021 | 352 | 0.150 |
Why?
|
Gene Expression Profiling | 4 | 2023 | 9507 | 0.140 |
Why?
|
Epigenomics | 2 | 2020 | 956 | 0.140 |
Why?
|
Cyclin-Dependent Kinase 4 | 1 | 2021 | 564 | 0.140 |
Why?
|
Neoplasm Recurrence, Local | 7 | 2024 | 9425 | 0.140 |
Why?
|
Ependymoma | 1 | 2020 | 324 | 0.140 |
Why?
|
Cerebellar Neoplasms | 1 | 2021 | 590 | 0.130 |
Why?
|
Medulloblastoma | 1 | 2021 | 682 | 0.130 |
Why?
|
Calcinosis | 1 | 2024 | 1485 | 0.120 |
Why?
|
Cell Proliferation | 5 | 2024 | 10494 | 0.120 |
Why?
|
Stem Cell Niche | 1 | 2018 | 348 | 0.120 |
Why?
|
Frizzled Receptors | 1 | 2014 | 91 | 0.110 |
Why?
|
Homeostasis | 1 | 2025 | 3351 | 0.110 |
Why?
|
Stem Cells | 2 | 2018 | 3538 | 0.110 |
Why?
|
Receptors, Notch | 1 | 2018 | 752 | 0.110 |
Why?
|
Interferons | 1 | 2017 | 714 | 0.110 |
Why?
|
Cell Culture Techniques | 1 | 2020 | 1669 | 0.100 |
Why?
|
Neural Pathways | 1 | 2023 | 3122 | 0.100 |
Why?
|
Proteomics | 2 | 2024 | 3901 | 0.100 |
Why?
|
Gene Expression Regulation, Neoplastic | 6 | 2025 | 8635 | 0.090 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2018 | 1660 | 0.090 |
Why?
|
Brain Neoplasms | 2 | 2023 | 9182 | 0.090 |
Why?
|
Humans | 25 | 2025 | 768451 | 0.080 |
Why?
|
Signal Transduction | 6 | 2024 | 23638 | 0.080 |
Why?
|
Glioblastoma | 1 | 2023 | 3523 | 0.070 |
Why?
|
Cell Line, Tumor | 5 | 2024 | 17149 | 0.070 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2017 | 2847 | 0.070 |
Why?
|
Animals | 8 | 2024 | 169418 | 0.070 |
Why?
|
Magnetic Resonance Imaging | 3 | 2024 | 36840 | 0.070 |
Why?
|
Repressor Proteins | 1 | 2017 | 2987 | 0.070 |
Why?
|
Transcription Factors | 2 | 2017 | 12174 | 0.070 |
Why?
|
World Health Organization | 2 | 2022 | 1328 | 0.060 |
Why?
|
Mice | 5 | 2024 | 82045 | 0.060 |
Why?
|
Tumor Suppressor Proteins | 1 | 2014 | 2819 | 0.060 |
Why?
|
Disease Models, Animal | 2 | 2021 | 18388 | 0.060 |
Why?
|
Macrophages | 1 | 2018 | 5797 | 0.050 |
Why?
|
Single-Cell Analysis | 2 | 2025 | 2531 | 0.050 |
Why?
|
Prognosis | 4 | 2024 | 30028 | 0.050 |
Why?
|
Informatics | 1 | 2022 | 71 | 0.050 |
Why?
|
11-beta-Hydroxysteroid Dehydrogenase Type 2 | 1 | 2021 | 18 | 0.050 |
Why?
|
Thrombospondin 1 | 1 | 2023 | 259 | 0.050 |
Why?
|
Reproducibility of Results | 1 | 2020 | 20231 | 0.050 |
Why?
|
Neurosurgical Procedures | 2 | 2024 | 2097 | 0.050 |
Why?
|
Cholesterol 7-alpha-Hydroxylase | 1 | 2021 | 28 | 0.050 |
Why?
|
MicroRNAs | 1 | 2017 | 3805 | 0.050 |
Why?
|
Receptor-Like Protein Tyrosine Phosphatases, Class 5 | 1 | 2020 | 18 | 0.050 |
Why?
|
Serine | 1 | 2024 | 831 | 0.040 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2023 | 712 | 0.040 |
Why?
|
beta Catenin | 1 | 2024 | 1048 | 0.040 |
Why?
|
NIH 3T3 Cells | 1 | 2021 | 669 | 0.040 |
Why?
|
Transcription Factor RelA | 1 | 2020 | 254 | 0.040 |
Why?
|
Breast Neoplasms | 2 | 2017 | 21156 | 0.040 |
Why?
|
Tumor Burden | 1 | 2024 | 1909 | 0.040 |
Why?
|
Ribosomes | 1 | 2021 | 500 | 0.040 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2022 | 1794 | 0.040 |
Why?
|
Retrospective Studies | 5 | 2024 | 81834 | 0.030 |
Why?
|
Tumor Cells, Cultured | 1 | 2024 | 6135 | 0.030 |
Why?
|
Genomics | 2 | 2024 | 5909 | 0.030 |
Why?
|
Wakefulness | 1 | 2023 | 1280 | 0.030 |
Why?
|
Cadherins | 1 | 2020 | 906 | 0.030 |
Why?
|
Histone-Lysine N-Methyltransferase | 1 | 2020 | 697 | 0.030 |
Why?
|
DNA Copy Number Variations | 1 | 2024 | 2046 | 0.030 |
Why?
|
Gene Knockout Techniques | 1 | 2018 | 808 | 0.030 |
Why?
|
Interleukin Receptor Common gamma Subunit | 1 | 2014 | 89 | 0.030 |
Why?
|
Morphogenesis | 1 | 2018 | 747 | 0.030 |
Why?
|
Genetic Markers | 1 | 2020 | 2604 | 0.030 |
Why?
|
Cell Count | 1 | 2018 | 1835 | 0.030 |
Why?
|
Wnt Proteins | 1 | 2018 | 724 | 0.030 |
Why?
|
Adult | 6 | 2024 | 223542 | 0.030 |
Why?
|
Phenotype | 2 | 2024 | 16712 | 0.030 |
Why?
|
Phosphorylation | 1 | 2024 | 8332 | 0.030 |
Why?
|
Calcium-Binding Proteins | 1 | 2018 | 1085 | 0.030 |
Why?
|
Chromosome Aberrations | 1 | 2020 | 1781 | 0.030 |
Why?
|
Mice, Transgenic | 2 | 2017 | 9558 | 0.030 |
Why?
|
Female | 8 | 2025 | 396943 | 0.030 |
Why?
|
Stromal Cells | 1 | 2018 | 1335 | 0.030 |
Why?
|
Lipid Metabolism | 1 | 2021 | 1898 | 0.030 |
Why?
|
Phylogeny | 1 | 2020 | 2846 | 0.020 |
Why?
|
Middle Aged | 5 | 2025 | 223418 | 0.020 |
Why?
|
Biopsy | 1 | 2023 | 6816 | 0.020 |
Why?
|
Ligands | 1 | 2018 | 3281 | 0.020 |
Why?
|
HeLa Cells | 1 | 2017 | 3090 | 0.020 |
Why?
|
Mice, Knockout | 2 | 2018 | 14480 | 0.020 |
Why?
|
Cell Differentiation | 2 | 2020 | 11674 | 0.020 |
Why?
|
Male | 6 | 2025 | 364781 | 0.020 |
Why?
|
Epigenesis, Genetic | 1 | 2024 | 3826 | 0.020 |
Why?
|
Mice, Inbred NOD | 1 | 2014 | 1839 | 0.020 |
Why?
|
Antigens, CD | 1 | 2020 | 4029 | 0.020 |
Why?
|
Aged | 4 | 2024 | 171520 | 0.020 |
Why?
|
Mice, SCID | 1 | 2014 | 2633 | 0.020 |
Why?
|
Transfection | 1 | 2017 | 5767 | 0.020 |
Why?
|
Aged, 80 and over | 2 | 2024 | 59680 | 0.020 |
Why?
|
Green Fluorescent Proteins | 1 | 2014 | 2072 | 0.020 |
Why?
|
Survival Rate | 1 | 2023 | 12875 | 0.020 |
Why?
|
Diffusion Magnetic Resonance Imaging | 1 | 2020 | 2823 | 0.020 |
Why?
|
Cohort Studies | 2 | 2022 | 41797 | 0.020 |
Why?
|
Microscopy, Confocal | 1 | 2014 | 1977 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2017 | 4294 | 0.020 |
Why?
|
Mice, Inbred C57BL | 2 | 2017 | 22365 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2014 | 4586 | 0.020 |
Why?
|
Multivariate Analysis | 1 | 2020 | 12096 | 0.020 |
Why?
|
Blotting, Western | 1 | 2014 | 5042 | 0.020 |
Why?
|
Mutation | 2 | 2022 | 30243 | 0.020 |
Why?
|
Neoplasm Metastasis | 1 | 2017 | 4931 | 0.020 |
Why?
|
Transplantation, Heterologous | 1 | 2014 | 2393 | 0.020 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2014 | 3794 | 0.020 |
Why?
|
Disease Progression | 1 | 2023 | 13655 | 0.020 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2021 | 5342 | 0.020 |
Why?
|
Cognition | 1 | 2023 | 7066 | 0.020 |
Why?
|
Cell Movement | 1 | 2017 | 5223 | 0.020 |
Why?
|
Proteins | 1 | 2020 | 6008 | 0.020 |
Why?
|
Protein Kinase Inhibitors | 1 | 2021 | 5709 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2024 | 39430 | 0.010 |
Why?
|
Epithelial Cells | 1 | 2014 | 3697 | 0.010 |
Why?
|
Algorithms | 1 | 2022 | 14158 | 0.010 |
Why?
|
Neurons | 1 | 2020 | 9504 | 0.010 |
Why?
|
Prospective Studies | 1 | 2023 | 54914 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2024 | 65409 | 0.010 |
Why?
|
Brain | 1 | 2023 | 27438 | 0.010 |
Why?
|
Risk Factors | 1 | 2020 | 74915 | 0.010 |
Why?
|